Concepedia

William G. Holloway

WG

4

Publications

96

Citations

4

H-Index

2007

Active since

Affiliations

Eli Lilly (United States)(Current)

William G. Holloway is an author at Eli Lilly (United States) specializing in pharmacotherapy, drug discovery, and medicine.

Top concepts

Publications per year

2007–2016

4

Publications

4

Lavendamycin Antitumor Agents: Structure-Based Design, Synthesis, and NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Model Validation with Molecular Docking and Biological Studies

Mary Hassani, Wen Cai, Katherine H. Koelsch et al. · Journal of Medicinal Chemistry · 2008 · 43 citations

Imidazopyridine and Pyrazolopiperidine Derivatives as Novel Inhibitors of Serine Palmitoyl Transferase

Michaël Génin, Isabel C. Gonzalez Valcarcel, William G. Holloway et al. · Journal of Medicinal Chemistry · 2016 · 31 citations · Full text

, , +23

Structure activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 2

Kumiko Takeuchi, William G. Holloway, Charles H. Mitch et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 12 citations · Full text

, , +9

Structure–activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 1

Kumiko Takeuchi, William G. Holloway, Jamie H. McKinzie et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 10 citations · Full text

, , +12

Rows per page

1–4 of 4